Ultragenyx Pharmaceutical, Inc. (RARE)
22.78
+3.06
(+15.52%)
USD |
NASDAQ |
Dec 30, 16:00
22.85
+0.07
(+0.31%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Market Cap: 2.198B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 81.40B |
| Amicus Therapeutics, Inc. | 4.395B |
| Geron Corp. | 852.20M |
| Vertex Pharmaceuticals, Inc. | 115.12B |
| Fortress Biotech, Inc. | 110.81M |
Market Cap Related Metrics
| PS Ratio | 3.524 |
| Price to Book Value | 239.96 |
| Price | 22.78 |
| Earnings Yield | -26.07% |